News & Views

BRAIN Biotech AG published in mid-June its first sustainability report and initial ESG data. We asked our colleague Michael Schneiders, Head of IR and Sustainability, about the background, challenges and next steps in sustainability at BRAIN.

BRAIN has acquired Breatec B.V. including the Comix business to further enhance the growth trajectory of BRAIN’s BioIndustrial division and expand its enzyme portfolio to adjacent market segments.

On January 17 BRAIN Biotech AG has published its Annual Report including the detailed consolidated financial statements for the fiscal year 2020/21.

WeissBioTech GmbH has announced that the company will be managed by a new leadership team, contributing expertise from biotech, finance and sales.

Biocatalysts has brought a new enzyme production facility on stream in a very short time, despite pandemic-related difficulties. Craig Galeozzie, Operations Director at Biocatalysts Ltd., reports on this experience.

The UN Global Compact pursues the vision of an inclusive and sustainable global economy for the benefit of all people, communities and markets. BRAIN Biotech AG supports this initiative.